(S)-2-氨基-3-(2,4,5-三羟基苯基)丙酸结构式
|
常用名 | (S)-2-氨基-3-(2,4,5-三羟基苯基)丙酸 | 英文名 | 6-Hydroxy-L-DOPA |
|---|---|---|---|---|
| CAS号 | 27244-64-0 | 分子量 | 213.19 | |
| 密度 | 1.606g/cm3 | 沸点 | 515.2ºC at 760mmHg | |
| 分子式 | C9H11NO5 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 265.4ºC |
(S)-2-氨基-3-(2,4,5-三羟基苯基)丙酸用途6-羟基-L-DOPA是一种用给电子单元官能化的核酸[1]。 |
| 中文名 | 左旋多巴杂质A |
|---|---|
| 英文名 | 6-hydroxy-L-dopa |
| 英文别名 | 更多 |
| 描述 | 6-羟基-L-DOPA是一种用给电子单元官能化的核酸[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.606g/cm3 |
|---|---|
| 沸点 | 515.2ºC at 760mmHg |
| 分子式 | C9H11NO5 |
| 分子量 | 213.19 |
| 闪点 | 265.4ºC |
| 精确质量 | 213.06400 |
| PSA | 124.01000 |
| LogP | 0.45810 |
| InChIKey | YLKRUSPZOTYMAT-YFKPBYRVSA-N |
| SMILES | NC(Cc1cc(O)c(O)cc1O)C(=O)O |
| 外观性状 | 固体 |
| 储存条件 | 2-8°C,干燥,避光 |
| 危害码 (欧洲) | Xi |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| 海关编码 | 2922509090 |
| 海关编码 | 2922509090 |
|---|---|
| 中文概述 | 2922509090. 其他氨基醇酚、氨基酸酚及其他含氧基氨基化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:AB. 最惠国关税:6.5%. 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
| 监管条件 | A.入境货物通关单 B.出境货物通关单 |
| 检验检疫 | R.进口食品卫生监督检验 S.出口食品卫生监督检验 |
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
The free radical site in pea seedling copper amine oxidase probed by resonance Raman spectroscopy and generated by photolysis of caged substrate.
FEBS Lett. 380(1-2) , 183-7, (1996) Resonance Raman spectra were obtained of the free radical site in substrate reduced anaerobic samples of pea seedling copper amine oxidase (PSAO). The spectra differ significantly from those reported ... |
|
|
Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Synapse 61 , 606-614, (2007) Evidence obtained in rodent and primate models of Parkinson's disease (PD) and preliminary clinical trials, indicates that adenosine A(2A) receptor antagonists might represent a promising nondopaminer... |
|
|
Up-regulation in expression of vesicular glutamate transporter 3 in substantia nigra but not in striatum of 6-hydroxydopamine-lesioned rats.
Neurosignals 15(5) , 238-48, (2006) Overactivity of the glutamatergic system is suggested to be closely related to the onset and pathogenesis of Parkinson's disease. Vesicular glutamate transporters (VGLUT1, T2 and T3) are a group of gl... |
|
实验名称:Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay
来源:ChEMBL
靶标:N/A
External Id:CHEMBL1266185
|
| L-Hydroxydopa |
| 2,4,5-trihydroxyphenyl-L-alanine |
| 2,4,5-trihydroxy-L-phenylalanine |
| 2,5-Dihydroxy-L-tyrosine |
| 2,5-Dihydroxy-L-tyrosine 3-(2,4,5-Trihydroxyphenyl)-L-alanine |
| L-6-Hydroxydopa |
| (2S)-2-amino-3-(2,4,5-trihydroxyphenyl)propanoic acid |
| 2,4,5,-trihydroxyphenylalanine |
| 2,4,5-Trihydroxyphenylalanine,L |
| 6-OH-DOPA |
| L-2,4,5-Trihydroxyphenylalanine |
| 6-Hydroxydopa |